ISG15 and hepatocellular carcinoma: Interestingly, in hepatocellular carcinoma (HCC) the nuclear factor erythroid 2-like 3 (NFE2L3), which has been largely involved in cancer development, induces the expression of ISG15 by binding to the antioxidant response element (ARE) located in the ISG15 promoter.